Subacute sclerosing panencephalitis

Seminars in Pediatric Neurology

Volumn 3, Issue 4, 1996, Pages 260-269

  Gascon, G G ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; MEASLES ANTIBODY; MEASLES VACCINE; METHISOPRINOL; RIBONUCLEOPROTEIN;

ANTIBODY TITER; CELL INCLUSION; CHILL; CLINICAL FEATURE; DEGENERATIVE DISEASE; ELECTROENCEPHALOGRAM; FEVER; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MEASLES VACCINATION; MEASLES VIRUS; NATURAL KILLER CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SLOW VIRUS DISEASE; SOMNOLENCE; SUBACUTE SCLEROSING PANENCEPHALITIS; VIRUS MUTANT;

EID: 0029952924     PISSN: 10719091     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9091(96)80030-1     Document Type: Article

References (81)

1. Dyken PR Cunningham SC Ward LC Changing character of subacute sclerosing panencephalitis in the United States Pediatr Neurol 5 1989 339 341
2. (editorial) Moodley M Subacute sclerosing panencephalitis in the developing world S Afr Med J 82 1992 72 73
3. Moodley M Moosa A Subacute sclerosing panencephalitis in black children—a review of 18 cases Quart J Med 76 1990 834 854
4. Haddad FS Risk WS Jabbour JT Subacute scherosing panencephalitis in the Middle East: report of 18 cases Quart J Med 76 1990 845 954
5. Khare S Kumari S Verghese T Subacute sclerosing panencephalitis in Delhi J Trop Pediat 40 1977 326 328
6. Fukuyama Y Nihei I Matsumoto S Clinical effects of MDN-19 on subacute sclerosing panencephalitis: a multiinstitutional collective study Brain Dev (Tokyo) 9 1987 270 282
7. Takayama S Iwasaki Y Yamanouchi H Characteristic clinical features in a case of fulminant sucacute sclerosing panencephalitis Brain Dev (Tokyo) 16 1994 132 135
8. Panitch HS Gomez-Plascencia J Norris FH Remission of sucacute scherosing panencephalitis in patients treated with intraventricular interferon Neurology 36 1986 562 566
9. Dyken PR Subacute sclerosing panencephalitis: current status Neurol Clin 3 1985 179 196
10. Dawson JR Cellular inclusions in cerebral lesions of lethargic encephalitis Am J Pathol 9 1933 7 16
11. (abstr) Dawson JR Cellular inclusions in cerebral lesions of lethargic encephalitis Arch Neurol Psychiatr 31 1934 685
12. van Bogaert L Rademaker J Hozay J Encephalitides 1961 Elsevier Amsterdam. The Netherlands
13. Zeman W Kolar O Reflections on the etiology and pathogenesis of subacute sclerosing panencephalitis. Part II Neurology 18 1968 1 7
14. Horta-Barbosa L Fuccillo DA London WT Isolation of measles virus from brain cell cultures of two patients with subacute sclerosing panencephalitis Proc Soc Exp Biol Med 132 1969 272 277
15. Payne FE Baublis JV Itabashi HH Isolation of measles virus from cell cultures of brain from a patient with subacute sclerosing panencephalitis N Engl J Med 281 1969 585 589
16. Chen TT Watanabe I Zeman W Subacute sclerosing panencephalitis propagation of measles virus from brain biopsy in tissue culture Science 163 1969 1193 1194
17. Bouteille M Guazzi GC Masselin S Particles d'aspect viral observées au microscope électronique dans une biopsie cérébrale d'encéphalite péri-axile diffuse de Schilder Presse Med 74 1966 2353 2354
18. Connolly HH Albin IV Hurwitz JH Measles antibody and antigen in subacute sclerosing panencephalitis Lancet 1 1967 542 544
19. Sigurdson B Ovservations on three slow infections of sheep. Maedi. Paratuberculosis. Rida. A chronic encephalitis of sheep with general remarks on infections which develop slowly, and some of their special characteristics Br Veter J 110 1954 255 270
20. Sigurdson B Ovservations on three slow infections of sheep. Maedi. Paratuberculosis. Rida. A chronic encephalitis of sheep with general remarks on infections which develop slowly, and some of their special characteristics Br Veter J 110 1954 307 322
21. Sigurdson B Ovservations on three slow infections of sheep. Maedi. Paratuberculosis. Rida. A chronic encephalitis of sheep with general remarks on infections which develop slowly, and some of their special characteristics Br Veter 110 1954 341 354
22. Ter Meulen V Hall WW Slow virus infections of the CNS: virological, immunological and pathogenetic considerations J Gen Virol 41 1978 1 25
23. Gajdusek DC Slow virus diseases of the central nervous system Am J Clin Pathol 56 1971 320
24. Gajdusek DC Gibbs CJ Jr Kuru, Creutzfeld-Jakob disease and transmissible presenile dementias ter Meulen V Katz M Show Virus Infections of the Central Nervous System 1977 Springer-Verlag New York, NY
25. Johnson RT Slow infections of the central nervous system causes by conventional viruses Ann NY Acad Sci 724 1994 6 13
26. Ho DD Rota TR Schooley RT Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome N Eng J Med 313 1985 1493 1497
27. Levy JA Shimabukuro J Hollander H Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms Lancet 2 1985 586 588
28. Johnson RT McArthur JC Narayan O The neurobiology of human immunodeficiency virus infections FASEB J 2 1988 2970 2981
29. Billeter MA Cattaneo R Spielhofer P Generation and properties of measles virus mutations typically associated with subacute sclerosing panencephalitis Ann NY Acad Sci 724 1994 367 377
30. Fujinami RS Oldstone MBA Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell Nature 279 1979 529 530
31. Sidhu MS Crowley J Lowenthal A Defective measles virus in human subacute sclerosing panencephalitis brain Virology 202 1994 631 641
32. chap 55 Norrby E Measles Fields BN Knipe DM Chanock RM Virology 1985 Raven New York, NY 1305 1321
33. Vandvik B Norrby E Oligoclonal IgG antibody response in the central nervous system to different measles virus antigens in subacute sclerosing panencephalitis Proc Nat Acad Sci USA 70 1973 1060 1063
34. Mehta PD Kane A Thormar H Quantitation of measles virus-specific immunoglobulins in serum, CSF and brain extract from patients with subacute sclerosing panencephalitis J Immunol 118 1977 2254 2261
35. Mathiesen T Hammarstrom L Fridell E Aberrant IgG subclass distribution to measles in healthy seropositive individuals, in patients with SSPE and in immunoglobulin-deficient patients Clin Exp Immunol 80 1990 202 205
36. Al-Sedairy STB Parhar RS Sheth K Immunological status of Saudi patients with SSPE International Child Neurology Association meeting Buenos Aires, Argentina November, 9–13, 1992
37. Dhib-Jalbut S Jacobson S McFarlin DE Impaired human leukocyte antigen-restricted measles virus-specific cytotoxic T-cell response in subacute sclerosing panencephalitis Ann Neurol 35 1989 272 280
38. Dhib-Jalbut S Jacobson S Cytotoxic T cells in paramyxovirus infection of humans Curr Topics Microbiol Immunol 189 1994 109 121
39. Finke D Brinckmann UG ter Muelen V Gamma interferon is a major mediator of antibiral defense in experimental measles virud-induced encephalitis J Virol 69 1995 5469 5475
40. Modlin JF Halsey NA Eddins DL Epidemiology of subacute sclerosing panencephalitis J Pediatr 94 1979 231 236
41. Barram TZ Gonzalez-Gomez I Xie ZD Subacute sclerosing panencephalitis in an infant: diagnostic role of viral genome analysis Ann Neurol 36 1994 103 108
42. Zwiauer K Forstenpointner E Popow-Kraupp T Rapid progressive subacute sclerosing panencephalitis after perinatally acquired measles virus infection Lancet 345 1995 1124
43. Cape CA Martinez AJ Robertson JT Adult onset of subacute sclerosing panencephalitis Arch Neurol 28 1973 124 127
44. Dyken P: Report of the National USA SSPE Registry, 1994
45. Yamani S Gascon GG Crowell J The myoclonus of subacute sclerosing panencephalitis: video-EEG studies International Child Neurology Association meetings Tokyo, Japan November, 1990
46. Robb RM Watters GW Ophthalmic manifestations of SSPE Arch Ophthal 83 1970 246
47. Jabbour JT Duenas DA Modlin J SSPE: clinical staging, course and frequency Arch Neurol 32 1975 493
48. Freeman JM The clinical spectrum of early diagnosis of Dawson's encephalitis J Pediatr 75 1979 590 603
49. Gascon GG Yamani S Crowell J Combined oral isoprinosine-intraventricular alpha interferon therapy for subacute sclerosing panencephalitis Brain Dev 15 1993 346 355
50. DuRant R II Dyken PR Swift AV The influence of inosiplex treatment on the neurological disability of patients with subacute sclerosing panencephalitis J Pediatr 101 1982 288 293
51. Dyken PR Swift A DuRant R II Long-term follow-up of patients with subacute sclerosing panencephalitis (SSPE) in the United States Ann Neurol 14 1983 586 587
52. Nester M Use of a brief assessment examination in a study of subacute sclerosing panencephalitis J Child Neurol 11 1996 1173 1180
53. Dyken PR Krawiecki NS DuRant RH The changing clinical expression of subacute sclerosing panencephalitis (SSPE) in the United States Ann Neurol 14 1983 586 587
54. Risk WS Haddad FS Chemali R Substantial spontaneous long-term improvement in subacute sclerosing panencephalitis. A study of 118 cases from the Middle East Arch Neurol 35 1978 494 502
55. Crowell J Clinical neurophysiology: video-EEG studies Symposium to ICNA/CNS Subacute Sclerosing Panencephalitis meeting: Update San Francisco, CA Oct 1, 1994
56. Lombroso CT Remarks on the EEG and movement disorder in SSPE Neurology 18 1968 69 75
57. Brismar J Gascon GG von Steyern KV Subacute sclerosing panencephalitis. Evaluation with CT and MR Am J Neuroradiol 17 1996 761 772
58. Cattaneo R Schmidt A Billeter MA Multiple viral mutations rather than host factors cause defective measles virug gene expression in an SSPE line J Virol 62 1988 1388 1397
59. Cattaneo R Schmid A Eschle D Biased hypermutation and other genetic changes in defective measles viruses in human brain infections Cell 55 1988 255 265
60. Aicardi J Goutieres F Arsenio-Nunes MI Acute measles encephalitis in chilren with immunosuppression Pediatrics 59 1977 232 239
61. Haslam RHA McQuillen MP Clark DB Amantadine therapy in subacute sclerosing panencephalitis Neurology 19 1969 1080 1085
62. Robertson WC Jr, Clark DB, Markesbery WR: Review of 39 cases of subacute sclerosing panencephalitis: effect of amantadine on the natural course of the disease Ann Neurol 8:42–425
63. Jones CE Dyken PR Huttenlocher PR Inosiplex therapy in subacute sclerosing panencephalitis: a multicentre, non-randomized study in 98 patients Lancet 1 1982 1034 1037
64. Huttenlocher PR Mattson RH Isoprinosine in subacute sclerosing panencephalitis Neurol 29 1979 763 771
65. Isaacs A Virus interference. I. The interferon Proc R Soc Lond (Biol) 147 1957 258 267
66. Fleischmann RW Jr Ramamurthy V Stanton GJ Interferon: mode of action and clinical applications Smith RA Interferon Treatment of Neurologic Disorders 1988 Marcel Dekker New York, NY 1 41
67. Lindahl P Leary P Gresser I Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes Proc Natl Acad Sci USA 69 1972 721 725
68. Gidlund M Orn A Wigzell H Enhanced NK activity in mice injected with interferon and interferon inducers Nature 273 1978 759 761
69. Einhorn S Blomgren H Strander H Interferon and spontaneous cytotoxicity in man. II. Studies in patients receiving exogenous leukocyte interferon Acta Med Scan 204 1978 477 483
70. Williams BRG Mocecular mechanisms of interferon action Smith RA Interferon Treatment of Neurologic Disorders 1988 Marcel Dekker New York, NY 43 63
71. Smith RA Kingsburn D Alksne J Distribution of interferon in cerebrospinal fluid after systemic, intrathecal and intraventricular administration Ann Neurol 12 1982 81
72. Rohatiner AZS Farkkila M Neurotoxicity of interferon therapy Smith RA Interferon Treatment of Neurologic Disorders 1988 Marcel Dekker New York, NY 135 143
73. Yalaz K Anlar B Oktem F Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis Neurol 42 1972 488 491
74. Panitch HS Treatment of subacute sclerosing panencephalitis with interferon Smith RA Interferon Treatment of Neurologic Disorders 1988 Marcel Dekker New York, NY 187 207
75. Anlar B Gucuyener K Imir T Cimetidine as an immunomodulator in subacute sclerosing panencephalitis: a double blind placebo-controlled study Pediatr Infect Dis J 12 1993 578 581
76. Al Rajeh S Kabiraj MMU Al Fawaz I Can cytotoxic drugs cure subacute sclerosing panencephalitis? Lancet 346 1995 377
77. Chiron C Dulac O Luna D Vigabatrin in infantile spasms Lancet 335 1990 363 364
78. Stratton KR Howe CJ Johnston RB Jr Adverse Events Associated with Childhood Vaccines, Evidence Bearing on Causality 1994 National Academy Press Washington, DC 51 52
79. Stratton KR Howe CJ Johnston RB Jr Adverse Events Associated with Childhood Vaccines, Evidence Bearing on Causality 1994 National Academy Press Washington, DC 140
80. Modlin JF Jabbour JT Witte JJ Epidemiologic studies of measles, measles vaccine and subacute sclerosing panencephalitis Pediatr 59 1977 505 512
81. Mehta PD Thormar H Kulczycki Immune response in subacute sclerosing panencephalitis Ann NY Acad Sci 724 1994 378 384